[
  {
    "ts": null,
    "headline": "The Dow Needs A Refresh. These New Members Could Make It Sing.",
    "summary": "The Dow Jones Industrial Average has lagged behind its flashier cousin, the S&P 500 index, in recent years, James Glassman writes in a guest commentary.",
    "url": "https://finnhub.io/api/news?id=e82be69ed4bcbc792f34e59ed7c1a1b8b7c37b5494550a933814d4112b3327a3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743784920,
      "headline": "The Dow Needs A Refresh. These New Members Could Make It Sing.",
      "id": 133727311,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "The Dow Jones Industrial Average has lagged behind its flashier cousin, the S&P 500 index, in recent years, James Glassman writes in a guest commentary.",
      "url": "https://finnhub.io/api/news?id=e82be69ed4bcbc792f34e59ed7c1a1b8b7c37b5494550a933814d4112b3327a3"
    }
  },
  {
    "ts": null,
    "headline": "Is Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic?",
    "summary": "According to the average brokerage recommendation (ABR), one should invest in Abbott (ABT). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?",
    "url": "https://finnhub.io/api/news?id=1f2879dda1cbb3c68d06884194aa6b44931575ea3f25bb7396767479fb642b43",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743773410,
      "headline": "Is Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic?",
      "id": 133719418,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "According to the average brokerage recommendation (ABR), one should invest in Abbott (ABT). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?",
      "url": "https://finnhub.io/api/news?id=1f2879dda1cbb3c68d06884194aa6b44931575ea3f25bb7396767479fb642b43"
    }
  },
  {
    "ts": null,
    "headline": "The Dow Needs a Refresh. These Stocks Could Make It Sing.",
    "summary": "The Dow Needs a Refresh. These Stocks Could Make It Sing.",
    "url": "https://finnhub.io/api/news?id=ed979c1be51b6f4e36b244296192a0879ec1626d908a150d5c1807c8e0828131",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743770520,
      "headline": "The Dow Needs a Refresh. These Stocks Could Make It Sing.",
      "id": 134147471,
      "image": "",
      "related": "ABT",
      "source": "MarketWatch",
      "summary": "The Dow Needs a Refresh. These Stocks Could Make It Sing.",
      "url": "https://finnhub.io/api/news?id=ed979c1be51b6f4e36b244296192a0879ec1626d908a150d5c1807c8e0828131"
    }
  },
  {
    "ts": null,
    "headline": "Reasons to Add ABT Stock to Your Portfolio Right Now",
    "summary": "Investors feel optimistic about Abbott's robust strength in the EPD, Diabetes and Nutrition businesses. However, unfavorable forex impacts are concerning.",
    "url": "https://finnhub.io/api/news?id=a60498d76edc6e0c6ba2b38b1f31ea6a3fdd45926f5d475825839779d2640449",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743768540,
      "headline": "Reasons to Add ABT Stock to Your Portfolio Right Now",
      "id": 133719419,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Investors feel optimistic about Abbott's robust strength in the EPD, Diabetes and Nutrition businesses. However, unfavorable forex impacts are concerning.",
      "url": "https://finnhub.io/api/news?id=a60498d76edc6e0c6ba2b38b1f31ea6a3fdd45926f5d475825839779d2640449"
    }
  },
  {
    "ts": null,
    "headline": "Q4 Rundown: Abbott Laboratories (NYSE:ABT) Vs Other Medical Devices & Supplies - Diversified Stocks",
    "summary": "Let’s dig into the relative performance of Abbott Laboratories (NYSE:ABT) and its peers as we unravel the now-completed Q4 medical devices & supplies - diversified earnings season.",
    "url": "https://finnhub.io/api/news?id=54d243827568dcbb59d0c4c170382db90f4e781d8e3376954cb2bd594b9202c1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743757287,
      "headline": "Q4 Rundown: Abbott Laboratories (NYSE:ABT) Vs Other Medical Devices & Supplies - Diversified Stocks",
      "id": 133704695,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Let’s dig into the relative performance of Abbott Laboratories (NYSE:ABT) and its peers as we unravel the now-completed Q4 medical devices & supplies - diversified earnings season.",
      "url": "https://finnhub.io/api/news?id=54d243827568dcbb59d0c4c170382db90f4e781d8e3376954cb2bd594b9202c1"
    }
  }
]